Much has changed in how we understand and treat eating disorders. Some significant aspects have remained consistent or ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Baszucki Group’s support has expanded the scope of the Cleveland Clinic Brain Study to include biomarkers from stool ...

Jeff Schaffnit discusses Sanofi's advancements in BTK inhibitors and promising results for hemophilia A therapies at ASH 2025 ...

A little-known provision in the Affordable Care Act allows patients to ask state-run panels to review decisions made by ...

Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% ...

Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...

The investigational orexin receptor 2 (OX2R) agonist oveporexton improved cognitive symptoms of narcolepsy type 1 (NT1) in secondary analysis of a phase II trial.

The 11:11 tattoo on Kristyne Agabob’s left wrist is inspired by numerology and represents a new beginning. “It’s a number that assures you that you’re on the right path,” she said. “It’s a constant ...

Daily use of cannabis has now surpassed daily use of alcohol. Understanding how it affects mental functioning can help users ...

Lehigh Valley Health Network held a ribbon-cutting Monday for Hanover Hills Behavioral Health, a three-story, ...

Peachtree Wellness Solutions has announced its expansion of mental health services in Atlanta, Georgia, by widening its ...